Basic HTML Version
医学遗传学与疾病研究
(
网络版
), 2012
年
,
第
1
卷
,
第
1
-
5
页
Yixue Yichuanxue Yu Jibing Yanjiu (Online), 2012, Vol.1, 1
-
5
http://mgdr.5th.sophiapublisher.com
4
PMid: 17881355
Cui W., Zhao Y., Shan C., Kong G., Hu N., Zhang Y., Zhang S.,
Zhang W., Zhang Y., Zhang X., and Ye L., 2012, HBXIP
upregulates CD46, CD55 and CD59 through
ERK1/2/NF-κB signaling to protect breast cancer cells
from complement attack, FEBS Lett., 586(6): 766-71
http://dx.doi.org/10.1016/j.febslet.2012.01.039
PMid:
22293503
Deveraux Q.L., and Reed J.C., 1999, IAP family proteins:
suppressors of apoptosis, Genes Dev., 13(3): 239-252
http://dx.doi.org/10.1101/gad.13.3.239
Dziembowski A., Piwowarski J., Hoser R., Minczuk M.,
Dmochowska A., Siep M., van der Spek H., Grivell L.,
and Stepien P.P., 2003, The yeast mitochondrial
degradosome. Its composition, interplay between RNA
helicase and RNase activities and the role in mitochondrial
RNA metabolism, J. Biol. Chem., 278(3): 1603-1611
http://dx.doi.org/10.1074/jbc.M208287200
PMid:
12426313
Dziembowski A., and Stepien P.P., 2001, Genetic and
biochemical approaches for analysis of mitochondrial
degradosome from Saccharomyces cerevisiae, Methods
Enzymol., 342: 367-378 http://dx.doi.org/10.1016/ S0076-
6879 (01)42559-6
Fujii R., Zhu C., Wen Y., Marusawa H., Bailly-Maitre B.,
Matsuzawa S., Zhang H., Kim Y., Bennett C.F., Jiang W.,
and Reed J.C., 2006, HBXIP, cellular target of hepatitis B
virus oncoprotein is a regulator of centrosome dynamics
and cytokinesis, Cancer Res., 66(18): 9099-9107
http://dx.doi.org/10.1158/0008-5472.CAN-06-1886
PMid:16982752
Gagliardi D., Stepien P.P., Temperley R.J., Lightowlers R.N.,
and Chrzanowska-Lightowlers Z.M., 2004, Messenger
RNA stability in mitochondria: Different means to an end,
Trends Genet., 20(6): 260-267 http://dx.doi.org/10.1016/
j.tig.2004.04.006 PMid:15145579
Garcia-Saez I., Lacroix F.B., Blot D., Gabel F., and Skoufias
D.A., 2011, Structural characterization of HBXIP: The
protein that interacts with the anti-apoptotic protein
survivin and the oncogenic viral protein HBx, J. Mol.
Biol., 405(2): 331-340 http://dx.doi.org/10.1016/j.jmb.
2010.10.046 PMid:21059355
Grossel M.J., and Hinds P.W., 2006, From cell cycle to
differentiation: An expanding role for cdk6, Cell Cycle,
5(3): 266-270 http://dx.doi.org/10.4161/cc.5.3.2385 PMid:
16410727
Hu N., Zhang J., Cui W., Kong G., Zhang S., Yue L., Bai X.,
Zhang Z., Zhang W., Zhang X., and Ye L., 2011,
miR-520b regulates migration of breast cancer cells by
targeting hepatitis B X-interacting protein and
interleukin-8, J. Biol. Chem., 286(15): 13714-13722
http://dx.doi.org/10.1074/jbc.M110.204131
PMid:21343296 PMCid:3075715
Jin L., Qian X., Kulig E., Sanno N., Scheithauer B.W., Kovacs
K., Young W.F. Jr, and Lloyd R.V. 1997, Transforming
growth factor2beta receptor II, and p27Kip1 expression in
nontumorous and neoplastic human pituitaries, Am. J.
Pathol., 151(2): 509-519 PMid:9250163 PMCid:1858020
Karin M., 2006, Nuclear factor-κB in cancer development and
progression, Nature, 441(7092): 431-436 http://dx.doi.org/
10.1038/nature04870 PMid:16724054
Marusawa H., Matsuzawa S., Welsh K., Zou H., Armstrong R.,
Tamm I., and Reed J.C., 2003, HBXIP functions as a
cofactor of survivin in apoptosis suppression, EMBO J.,
22(11):
2729-2740
http://dx.doi.org/10.1093/emboj/
cdg263 PMid:12773388 PMCid:156760
Melegari M., Scaglioni P.P., and Wands J.R., 1998, Cloning and
characterization of a novel hepatitis B virus x binding
protein that inhibits viral replication, J. Virol., 72(3):
1737-1743 PMid:9499022 PMCid:109461
Minczuk M., Lilpop J., Boros J., and Stepien P.P., 2005a, The 5’
region of the human hSUV3 gene encoding mitochondrial
DNA and RNA helicase: Promoter characterization and
alternative pre-mRNA splicing, Biochim. Biophys. Acta,
1729(2): 81-87
Minczuk M., Mroczek S., Pawlak S.D., and Stepien P.P., 2005b,
Human ATP-dependent RNA/DNA helicase hSuv3p
interacts with the cofactor of survivin HBXIP, FEBS J.,
272(19): 5008-5019 http://dx.doi.org/10.1111/j.1742-4658.
2005.04910.x PMid:16176273
Pahl H.L., 1999, Activators and target genes of Rel/NF-kappaB
transcription factors, Oncogene, 18(49): 6853-6866
http://dx.doi.org/10.1038/sj.onc.1203239 PMid:10602461
Pines J., 1995, Cyclins, CDKs and cancer, Semin. Cancer Biol.,
6(2): 63-72 http://dx.doi.org/10.1006/scbi.1995.0009
PMid: 7647308
Shu Z., Vijayakumar S., Chen C.F., Chen P.L., and Lee W.H.,
2004, Purified human SUV3p exhibits multiple-substrate
unwinding activity upon conformational change,
Biochemistry, 43(16): 4781-4790 http://dx.doi.org/